Guests: Mr. Omid Moghadam and Dr. Anna Daily discuss their brand new accurate, fast, and inexpensive breast cancer screening by testing tears for specific proteins.
Dr. Anna Daily, Ph.D., is the Vice President of Product Development and Innovation at Namida Lab where she works to establish clinical, industrial, and academic partnerships both locally and across the country. Anna is lead inventor of Auria®, Namida’s novel tear-based breast health assessment test, and has had the opportunity to present this work both nationally and internationally. Dr. Daily received her Ph.D. in Cellular and Molecular Biology from the University of Arkansas and provides expertise in the expression and purification of recombinant proteins, genetic engineering/cloning, as well as numerous biophysical and analytical chemistry techniques towards the characterization of proteins.
Mr. Omid Moghadam is the founder and CEO of Namida Lab, a clinical stage diagnostics company, specializing in development and commercialization of liquid biopsy tests for early detection of cancer. Namida’s first product, Melody, is an accurate, fast and inexpensive screening test for breast cancer. Omid is an inventor, entrepreneur, venture investor and educator. He is the past founder or co-founder of nine companies in Healthcare IT, genomics, diagnostics and medical imaging, and has held executive positions at Intel, Eastman Kodak and CTG-AMS Corporations.
For more info: rejuvinatedmedspa.com
